SilVia Bio develops cell profiling and media additive solutions to optimize mammalian cell biomanufacturing processes.
SILVIA BIO has raised $4.0M in total funding. The most recent round was Seed. The last funding was announced in October 2026.
SILVIA BIO's investors include Northern Gritstone, UK Innovation & Science Seed Fund, Northern Universities Venture Fund, Wren Capital.
SILVIA BIO is headquartered in Sheffield, United Kingdom.
SilVia Bio develops cell profiling and media additive solutions to optimize mammalian cell biomanufacturing processes.
SILVIA BIO is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SILVIA BIO — Funding & Investors." VCBacked, October 15, 2026, https://www.vcbacked.co/company/silvia-bio. Accessed November 2, 2026.
VCBacked. (2026). SILVIA BIO — Funding & Investors. Retrieved November 2, 2026, from https://www.vcbacked.co/company/silvia-bio
{{cite web |title=SILVIA BIO — Funding & Investors |url=https://www.vcbacked.co/company/silvia-bio |website=VCBacked |access-date=November 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at SILVIA BIO? Request a listing update